Kramer et al. then examined GAB2 mRNA levels in primary human AML samples from The Cancer Genome Atlas (TCGA) database and found that GAB2 expression was higher in PML::RARA-positive tumor samples than in normal CD34+ cells (22). This evidence concerns the gene GAB2 and acute myeloid leukemia.